TY - JOUR AU - Cooper, C. S. AU - Park, M. AU - Blair, D. G. AU - Tainsky, M. A. AU - Huebner, K. AU - Croce, C. M. PY - 1984 DA - 1984// TI - Molecular cloning of a new transforming gene from a chemically transformed human cell line JO - Nature VL - 311 UR - https://doi.org/10.1038/311029a0 DO - 10.1038/311029a0 ID - Cooper1984 ER - TY - JOUR AU - Comoglio, P. M. AU - Giordano, S. AU - Trusolino, L. PY - 2008 DA - 2008// TI - Drug development of MET inhibitors: targeting oncogene addiction and expedience JO - Nat Rev Drug Discov VL - 7 UR - https://doi.org/10.1038/nrd2530 DO - 10.1038/nrd2530 ID - Comoglio2008 ER - TY - JOUR AU - Gherardi, E. AU - Youles, M. E. AU - Miguel, R. N. AU - Blundell, T. L. AU - Iamele, L. AU - Gough, J. PY - 2003 DA - 2003// TI - Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.2034936100 DO - 10.1073/pnas.2034936100 ID - Gherardi2003 ER - TY - JOUR AU - Nakamura, T. AU - Nishizawa, T. AU - Hagiya, M. AU - Seki, T. AU - Shimonishi, M. AU - Sugimura, A. PY - 1989 DA - 1989// TI - Molecular cloning and expression of human hepatocyte growth factor JO - Nature VL - 342 UR - https://doi.org/10.1038/342440a0 DO - 10.1038/342440a0 ID - Nakamura1989 ER - TY - JOUR AU - Miyazawa, K. AU - Tsubouchi, H. AU - Naka, D. AU - Takahashi, K. AU - Okigaki, M. AU - Arakaki, N. PY - 1989 DA - 1989// TI - Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor JO - Biochem Biophys Res Commun VL - 163 UR - https://doi.org/10.1016/0006-291X(89)92316-4 DO - 10.1016/0006-291X(89)92316-4 ID - Miyazawa1989 ER - TY - JOUR AU - Stoker, M. AU - Gherardi, E. AU - Perryman, M. AU - Gray, J. PY - 1987 DA - 1987// TI - Scatter factor is a fibroblast-derived modulator of epithelial cell mobility JO - Nature VL - 327 UR - https://doi.org/10.1038/327239a0 DO - 10.1038/327239a0 ID - Stoker1987 ER - TY - JOUR AU - Bottaro, D. P. AU - Rubin, J. S. AU - Faletto, D. L. AU - Chan, A. M. AU - Kmiecik, T. E. AU - Vande Woude, G. F. PY - 1991 DA - 1991// TI - Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product JO - Science VL - 251 UR - https://doi.org/10.1126/science.1846706 DO - 10.1126/science.1846706 ID - Bottaro1991 ER - TY - JOUR AU - Birchmeier, C. AU - Birchmeier, W. AU - Gherardi, E. AU - Vande Woude, G. F. PY - 2003 DA - 2003// TI - Met, metastasis, motility and more JO - Nat Rev Mol Cell Biol VL - 4 UR - https://doi.org/10.1038/nrm1261 DO - 10.1038/nrm1261 ID - Birchmeier2003 ER - TY - JOUR AU - Rodrigues, G. A. AU - Park, M. PY - 1994 DA - 1994// TI - Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase JO - Oncogene VL - 9 ID - Rodrigues1994 ER - TY - JOUR AU - Fixman, E. D. AU - Fournier, T. M. AU - Kamikura, D. M. AU - Naujokas, M. A. AU - Park, M. PY - 1996 DA - 1996// TI - Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.22.13116 DO - 10.1074/jbc.271.22.13116 ID - Fixman1996 ER - TY - JOUR AU - Pelicci, G. AU - Giordano, S. AU - Zhen, Z. AU - Salcini, A. E. AU - Lanfrancone, L. AU - Bardelli, A. PY - 1995 DA - 1995// TI - The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein JO - Oncogene VL - 10 ID - Pelicci1995 ER - TY - JOUR AU - Sakkab, D. AU - Lewitzky, M. AU - Posern, G. AU - Schaeper, U. AU - Sachs, M. AU - Birchmeier, W. PY - 2000 DA - 2000// TI - Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.275.15.10772 DO - 10.1074/jbc.275.15.10772 ID - Sakkab2000 ER - TY - JOUR AU - Garcia-Guzman, M. AU - Dolfi, F. AU - Zeh, K. AU - Vuori, K. PY - 1999 DA - 1999// TI - Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1-Crk signaling complex formation JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1203198 DO - 10.1038/sj.onc.1203198 ID - Garcia-Guzman1999 ER - TY - JOUR AU - Organ, S. L. AU - Tsao, M. S. PY - 2011 DA - 2011// TI - An overview of the c-MET signaling pathway JO - Ther Adv Med Oncol VL - 3 UR - https://doi.org/10.1177/1758834011422556 DO - 10.1177/1758834011422556 ID - Organ2011 ER - TY - JOUR AU - Trusolino, L. AU - Bertotti, A. AU - Comoglio, P. M. PY - 2010 DA - 2010// TI - MET signalling: principles and functions in development, organ regeneration and cancer JO - Nat Rev Mol Cell Biol VL - 11 UR - https://doi.org/10.1038/nrm3012 DO - 10.1038/nrm3012 ID - Trusolino2010 ER - TY - JOUR AU - Liu, X. AU - Yao, W. AU - Newton, R. C. AU - Scherle, P. A. PY - 2008 DA - 2008// TI - Targeting the c-MET signaling pathway for cancer therapy JO - Expert Opin Investig Drugs VL - 17 UR - https://doi.org/10.1517/13543784.17.7.997 DO - 10.1517/13543784.17.7.997 ID - Liu2008 ER - TY - JOUR AU - Peruzzi, B. AU - Bottaro, D. P. PY - 2006 DA - 2006// TI - Targeting the c-Met signaling pathway in cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0818 DO - 10.1158/1078-0432.CCR-06-0818 ID - Peruzzi2006 ER - TY - JOUR AU - Paumelle, R. AU - Tulasne, D. AU - Kherrouche, Z. AU - Plaza, S. AU - Leroy, C. AU - Reveneau, S. PY - 2002 DA - 2002// TI - Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205297 DO - 10.1038/sj.onc.1205297 ID - Paumelle2002 ER - TY - JOUR AU - Xiao, G. H. AU - Jeffers, M. AU - Bellacosa, A. AU - Mitsuuchi, Y. AU - Vande Woude, G. F. AU - Testa, J. R. PY - 2001 DA - 2001// TI - Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.98.1.247 DO - 10.1073/pnas.98.1.247 ID - Xiao2001 ER - TY - JOUR AU - Krause, D. S. AU - Etten, R. A. PY - 2005 DA - 2005// TI - Tyrosine kinases as targets for cancer therapy JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra044389 DO - 10.1056/NEJMra044389 ID - Krause2005 ER - TY - JOUR AU - Christensen, J. G. AU - Burrows, J. AU - Salgia, R. PY - 2005 DA - 2005// TI - c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention JO - Cancer Lett VL - 225 UR - https://doi.org/10.1016/j.canlet.2004.09.044 DO - 10.1016/j.canlet.2004.09.044 ID - Christensen2005 ER - TY - JOUR AU - Weidner, K. M. AU - Behrens, J. AU - Vandekerckhove, J. AU - Birchmeier, W. PY - 1990 DA - 1990// TI - Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells JO - J Cell Biol VL - 111 UR - https://doi.org/10.1083/jcb.111.5.2097 DO - 10.1083/jcb.111.5.2097 ID - Weidner1990 ER - TY - JOUR AU - Rosen, E. M. AU - Goldberg, I. D. PY - 1997 DA - 1997// TI - Regulation of angiogenesis by scatter factor JO - EXS VL - 79 ID - Rosen1997 ER - TY - JOUR AU - Abounader, R. AU - Lal, B. AU - Luddy, C. AU - Koe, G. AU - Davidson, B. AU - Rosen, E. M. PY - 2002 DA - 2002// TI - In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis JO - FASEB J VL - 16 ID - Abounader2002 ER - TY - JOUR AU - Danilkovitch-Miagkova, A. AU - Zbar, B. PY - 2002 DA - 2002// TI - Dysregulation of Met receptor tyrosine kinase activity in invasive tumors JO - J Clin Invest VL - 109 UR - https://doi.org/10.1172/JCI0215418 DO - 10.1172/JCI0215418 ID - Danilkovitch-Miagkova2002 ER - TY - JOUR AU - Wang, R. AU - Ferrell, L. D. AU - Faouzi, S. AU - Maher, J. J. AU - Bishop, J. M. PY - 2001 DA - 2001// TI - Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice JO - J Cell Biol VL - 153 UR - https://doi.org/10.1083/jcb.153.5.1023 DO - 10.1083/jcb.153.5.1023 ID - Wang2001 ER - TY - JOUR AU - Jo, M. AU - Stolz, D. B. AU - Esplen, J. E. AU - Dorko, K. AU - Michalopoulos, G. K. AU - Strom, S. C. PY - 2000 DA - 2000// TI - Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.275.12.8806 DO - 10.1074/jbc.275.12.8806 ID - Jo2000 ER - TY - JOUR AU - Puri, N. AU - Salgia, R. PY - 2008 DA - 2008// TI - Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer JO - J Carcinog VL - 7 UR - https://doi.org/10.4103/1477-3163.44372 DO - 10.4103/1477-3163.44372 ID - Puri2008 ER - TY - JOUR AU - Bachleitner-Hofmann, T. AU - Sun, M. Y. AU - Chen, C. T. AU - Tang, L. AU - Song, L. AU - Zeng, Z. PY - 2008 DA - 2008// TI - HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0374 DO - 10.1158/1535-7163.MCT-08-0374 ID - Bachleitner-Hofmann2008 ER - TY - JOUR AU - Follenzi, A. AU - Bakovic, S. AU - Gual, P. AU - Stella, M. C. AU - Longati, P. AU - Comoglio, P. M. PY - 2000 DA - 2000// TI - Cross-talk between the proto-oncogenes Met and Ron JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203620 DO - 10.1038/sj.onc.1203620 ID - Follenzi2000 ER - TY - JOUR AU - Yeh, C. Y. AU - Shin, S. M. AU - Yeh, H. H. AU - Wu, T. J. AU - Shin, J. W. AU - Chang, T. Y. PY - 2011 DA - 2011// TI - Transcriptional activation of the Axl and PDGFR-alpha by c-Met through a ras- and Src-independent mechanism in human bladder cancer JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-139 DO - 10.1186/1471-2407-11-139 ID - Yeh2011 ER - TY - JOUR AU - Furge, K. A. AU - Kiewlich, D. AU - Le, P. AU - Vo, M. N. AU - Faure, M. AU - Howlett, A. R. PY - 2001 DA - 2001// TI - Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.191067898 DO - 10.1073/pnas.191067898 ID - Furge2001 ER - TY - JOUR AU - Liu, X. AU - Newton, R. C. AU - Scherle, P. A. PY - 2010 DA - 2010// TI - Developing c-MET pathway inhibitors for cancer therapy: progress and challenges JO - Trends Mol Med VL - 16 UR - https://doi.org/10.1016/j.molmed.2009.11.005 DO - 10.1016/j.molmed.2009.11.005 ID - Liu2010 ER - TY - JOUR AU - Mueller, K. L. AU - Hunter, L. A. AU - Ethier, S. P. AU - Boerner, J. L. PY - 2008 DA - 2008// TI - Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0132 DO - 10.1158/0008-5472.CAN-08-0132 ID - Mueller2008 ER - TY - JOUR AU - Sano, Y. AU - Hashimoto, E. AU - Nakatani, N. AU - Abe, M. AU - Satoh, Y. AU - Sakata, K. PY - 2015 DA - 2015// TI - Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0456 DO - 10.1158/1535-7163.MCT-14-0456 ID - Sano2015 ER - TY - JOUR AU - Spigel, D. R. AU - Edelman, M. J. AU - O’Byrne, K. AU - Paz-Ares, L. AU - Mocci, S. AU - Phan, S. PY - 2017 DA - 2017// TI - Results from the phase III randomized trial of onartuzumab plus erlotinib versus erlotinib in previously treated stage IIIB or IV non-small-cell lung cancer: METLung JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.69.2160 DO - 10.1200/JCO.2016.69.2160 ID - Spigel2017 ER - TY - JOUR AU - Yang, R. AU - Bunting, S. AU - Ko, A. AU - Schwall, R. AU - Jin, H. PY - 1997 DA - 1997// TI - Hemodynamic effects of scatter factor in conscious rats JO - J Cardiovasc Pharmacol VL - 30 UR - https://doi.org/10.1097/00005344-199709000-00004 DO - 10.1097/00005344-199709000-00004 ID - Yang1997 ER - TY - JOUR AU - Kaplan, O. AU - Firon, M. AU - Vivi, A. AU - Navon, G. AU - Tsarfaty, I. PY - 2000 DA - 2000// TI - HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells JO - Neoplasia VL - 2 UR - https://doi.org/10.1038/sj.neo.7900103 DO - 10.1038/sj.neo.7900103 ID - Kaplan2000 ER - TY - JOUR AU - Shaharabany, M. AU - Abramovitch, R. AU - Kushnir, T. AU - Tsarfaty, G. AU - Ravid-Megido, M. AU - Horev, J. PY - 2001 DA - 2001// TI - In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors JO - Cancer Res VL - 61 ID - Shaharabany2001 ER - TY - JOUR AU - Tsarfaty, G. AU - Stein, G. Y. AU - Moshitch-Moshkovitz, S. AU - Kaufman, D. W. AU - Cao, B. AU - Resau, J. H. PY - 2006 DA - 2006// TI - HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met JO - Neoplasia VL - 8 UR - https://doi.org/10.1593/neo.05685 DO - 10.1593/neo.05685 ID - Tsarfaty2006 ER - TY - JOUR AU - Luo, H. AU - Hong, H. AU - Slater, M. R. AU - Graves, S. A. AU - Shi, S. AU - Yang, Y. PY - 2015 DA - 2015// TI - PET of c-Met in cancer with 64Cu-labeled hepatocyte growth factor JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.154690 DO - 10.2967/jnumed.115.154690 ID - Luo2015 ER - TY - JOUR AU - Corcoran, E. B. AU - Hanson, R. N. PY - 2014 DA - 2014// TI - Imaging EGFR and HER2 by PET and SPECT: a review JO - Med Res Rev VL - 34 UR - https://doi.org/10.1002/med.21299 DO - 10.1002/med.21299 ID - Corcoran2014 ER - TY - JOUR AU - Hay, R. V. AU - Cao, B. AU - Skinner, R. S. AU - Wang, L. M. AU - Su, Y. AU - Resau, J. H. PY - 2002 DA - 2002// TI - Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor JO - Mol Imaging VL - 1 UR - https://doi.org/10.1162/153535002753395716 DO - 10.1162/153535002753395716 ID - Hay2002 ER - TY - JOUR AU - Hay, R. V. AU - Cao, B. AU - Skinner, R. S. AU - Su, Y. AU - Zhao, P. AU - Gustafson, M. F. PY - 2005 DA - 2005// TI - Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek) JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-1004-0014 DO - 10.1158/1078-0432.CCR-1004-0014 ID - Hay2005 ER - TY - JOUR AU - Hay, R. V. AU - Cao, B. AU - Skinner, R. S. AU - Wang, L. M. AU - Su, Y. AU - Resau, J. H. PY - 2003 DA - 2003// TI - Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody JO - Clin Cancer Res VL - 9 ID - Hay2003 ER - TY - JOUR AU - Jiao, Y. AU - Zhao, P. AU - Zhu, J. AU - Grabinski, T. AU - Feng, Z. AU - Guan, X. PY - 2005 DA - 2005// TI - Construction of human naive Fab library and characterization of anti-met Fab fragment generated from the library JO - Mol Biotechnol VL - 31 UR - https://doi.org/10.1385/MB:31:1:041 DO - 10.1385/MB:31:1:041 ID - Jiao2005 ER - TY - JOUR AU - Knudsen, B. S. AU - Zhao, P. AU - Resau, J. AU - Cottingham, S. AU - Gherardi, E. AU - Xu, E. PY - 2009 DA - 2009// TI - A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings JO - Appl Immunohistochem Mol Morphol VL - 17 UR - https://doi.org/10.1097/PAI.0b013e3181816ae2 DO - 10.1097/PAI.0b013e3181816ae2 ID - Knudsen2009 ER - TY - JOUR AU - Divgi, C. R. AU - Pandit-Taskar, N. AU - Jungbluth, A. A. AU - Reuter, V. E. AU - Gonen, M. AU - Ruan, S. PY - 2007 DA - 2007// TI - Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial JO - Lancet Oncol VL - 8 UR - https://doi.org/10.1016/S1470-2045(07)70044-X DO - 10.1016/S1470-2045(07)70044-X ID - Divgi2007 ER - TY - JOUR AU - Rahmim, A. AU - Zaidi, H. PY - 2008 DA - 2008// TI - PET versus SPECT: strengths, limitations and challenges JO - Nucl Med Commun VL - 29 UR - https://doi.org/10.1097/MNM.0b013e3282f3a515 DO - 10.1097/MNM.0b013e3282f3a515 ID - Rahmim2008 ER - TY - JOUR AU - Perk, L. R. AU - Stigter-van Walsum, M. AU - Visser, G. W. AU - Kloet, R. W. AU - Vosjan, M. J. AU - Leemans, C. R. PY - 2008 DA - 2008// TI - Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 JO - Eur J Nucl Med Mol Imaging VL - 35 UR - https://doi.org/10.1007/s00259-008-0774-5 DO - 10.1007/s00259-008-0774-5 ID - Perk2008 ER - TY - JOUR AU - Jagoda, E. M. AU - Lang, L. AU - Bhadrasetty, V. AU - Histed, S. AU - Williams, M. AU - Kramer-Marek, G. PY - 2012 DA - 2012// TI - Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.102293 DO - 10.2967/jnumed.111.102293 ID - Jagoda2012 ER - TY - JOUR AU - Li, K. AU - Tavare, R. AU - Zettlitz, K. A. AU - Mumenthaler, S. M. AU - Mallick, P. AU - Zhou, Y. PY - 2014 DA - 2014// TI - Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-14-0363 DO - 10.1158/1535-7163.MCT-14-0363 ID - Li2014 ER - TY - JOUR AU - Lu, R. M. AU - Chang, Y. L. AU - Chen, M. S. AU - Wu, H. C. PY - 2011 DA - 2011// TI - Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery JO - Biomaterials VL - 32 UR - https://doi.org/10.1016/j.biomaterials.2010.12.061 DO - 10.1016/j.biomaterials.2010.12.061 ID - Lu2011 ER - TY - JOUR AU - Towner, R. A. AU - Smith, N. AU - Doblas, S. AU - Tesiram, Y. AU - Garteiser, P. AU - Saunders, D. PY - 2008 DA - 2008// TI - In vivo detection of c-Met expression in a rat C6 glioma model JO - J Cell Mol Med VL - 12 UR - https://doi.org/10.1111/j.1582-4934.2008.00220.x DO - 10.1111/j.1582-4934.2008.00220.x ID - Towner2008 ER - TY - JOUR AU - Doblas, S. AU - Saunders, D. AU - Kshirsagar, P. AU - Pye, Q. AU - Oblander, J. AU - Gordon, B. PY - 2008 DA - 2008// TI - Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model JO - Free Radic Biol Med VL - 44 UR - https://doi.org/10.1016/j.freeradbiomed.2007.09.006 DO - 10.1016/j.freeradbiomed.2007.09.006 ID - Doblas2008 ER - TY - JOUR AU - Towner, R. A. AU - Smith, N. AU - Tesiram, Y. A. AU - Abbott, A. AU - Saunders, D. AU - Blindauer, R. PY - 2007 DA - 2007// TI - In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging JO - Mol Imaging VL - 6 ID - Towner2007 ER - TY - JOUR AU - Towner, R. A. AU - Smith, N. AU - Asano, Y. AU - Doblas, S. AU - Saunders, D. AU - Silasi-Mansat, R. PY - 2010 DA - 2010// TI - Molecular magnetic resonance imaging approaches used to aid in the understanding of the tissue regeneration marker Met in vivo: implications for tissue engineering JO - Tissue Eng Part A VL - 16 UR - https://doi.org/10.1089/ten.tea.2009.0234 DO - 10.1089/ten.tea.2009.0234 ID - Towner2010 ER - TY - JOUR AU - Hasebroock, K. M. AU - Serkova, N. J. PY - 2009 DA - 2009// TI - Toxicity of MRI and CT contrast agents JO - Expert Opin Drug Metab Toxicol VL - 5 UR - https://doi.org/10.1517/17425250902873796 DO - 10.1517/17425250902873796 ID - Hasebroock2009 ER - TY - JOUR AU - Thorek, D. L. AU - Chen, A. K. AU - Czupryna, J. AU - Tsourkas, A. PY - 2006 DA - 2006// TI - Superparamagnetic iron oxide nanoparticle probes for molecular imaging JO - Ann Biomed Eng VL - 34 UR - https://doi.org/10.1007/s10439-005-9002-7 DO - 10.1007/s10439-005-9002-7 ID - Thorek2006 ER - TY - JOUR AU - Chen, K. AU - Chen, X. PY - 2010 DA - 2010// TI - Design and development of molecular imaging probes JO - Curr Top Med Chem VL - 10 UR - https://doi.org/10.2174/156802610791384225 DO - 10.2174/156802610791384225 ID - Chen2010 ER - TY - JOUR AU - Zhao, P. AU - Grabinski, T. AU - Gao, C. AU - Skinner, R. S. AU - Giambernardi, T. AU - Su, Y. PY - 2007 DA - 2007// TI - Identification of a met-binding peptide from a phage display library JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0035 DO - 10.1158/1078-0432.CCR-07-0035 ID - Zhao2007 ER - TY - JOUR AU - Kim, E. M. AU - Park, E. H. AU - Cheong, S. J. AU - Lee, C. M. AU - Kim, D. W. AU - Jeong, H. J. PY - 2009 DA - 2009// TI - Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts JO - Nucl Med Biol VL - 36 UR - https://doi.org/10.1016/j.nucmedbio.2009.01.005 DO - 10.1016/j.nucmedbio.2009.01.005 ID - Kim2009 ER - TY - JOUR AU - Kim, E. M. AU - Park, E. H. AU - Cheong, S. J. AU - Lee, C. M. AU - Jeong, H. J. AU - Kim, D. W. PY - 2009 DA - 2009// TI - In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system JO - Bioconjug Chem VL - 20 UR - https://doi.org/10.1021/bc8005539 DO - 10.1021/bc8005539 ID - Kim2009 ER - TY - JOUR AU - Burggraaf, J. AU - Kamerling, I. M. AU - Gordon, P. B. AU - Schrier, L. AU - Kam, M. L. AU - Kales, A. J. PY - 2015 DA - 2015// TI - Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3641 DO - 10.1038/nm.3641 ID - Burggraaf2015 ER - TY - JOUR AU - Liu, S. AU - Zheng, Y. AU - Volpi, D. AU - El-Kasti, M. AU - Klotz, D. AU - Tullis, I. PY - 2015 DA - 2015// TI - Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.29029 DO - 10.1002/cncr.29029 ID - Liu2015 ER - TY - JOUR AU - Arulappu, A. AU - Battle, M. AU - Eisenblaetter, M. AU - McRobbie, G. AU - Khan, I. AU - Monypenny, J. PY - 2016 DA - 2016// TI - c-Met PET imaging detects early-stage locoregional recurrence of basal-like breast cancer JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.164384 DO - 10.2967/jnumed.115.164384 ID - Arulappu2016 ER - TY - JOUR AU - Garcia-Allende, P. B. AU - Glatz, J. AU - Koch, M. AU - Ntziachristos, V. PY - 2013 DA - 2013// TI - Enriching the interventional vision of cancer with fluorescence and optoacoustic imaging JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.111.099796 DO - 10.2967/jnumed.111.099796 ID - Garcia-Allende2013 ER - TY - JOUR AU - Jagoda, E. M. AU - Bhattacharyya, S. AU - Kalen, J. AU - Riffle, L. AU - Leeder, A. AU - Histed, S. PY - 2015 DA - 2015// TI - Imaging the Met receptor tyrosine kinase (Met) and assessing tumor responses to a Met tyrosine kinase inhibitor in human xenograft mouse models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) labeled peptide JO - Mol Imaging VL - 14 ID - Jagoda2015 ER - TY - JOUR AU - Gross, S. AU - Piwnica-Worms, D. PY - 2005 DA - 2005// TI - Spying on cancer: molecular imaging in vivo with genetically encoded reporters JO - Cancer Cell VL - 7 ID - Gross2005 ER - TY - JOUR AU - Razgulin, A. AU - Ma, N. AU - Rao, J. PY - 2011 DA - 2011// TI - Strategies for in vivo imaging of enzyme activity: an overview and recent advances JO - Chem Soc Rev VL - 40 UR - https://doi.org/10.1039/c1cs15035a DO - 10.1039/c1cs15035a ID - Razgulin2011 ER - TY - JOUR AU - Zhang, L. AU - Virani, S. AU - Zhang, Y. AU - Bhojani, M. S. AU - Burgess, T. L. AU - Coxon, A. PY - 2011 DA - 2011// TI - Molecular imaging of c-Met tyrosine kinase activity JO - Anal Biochem VL - 412 UR - https://doi.org/10.1016/j.ab.2011.01.028 DO - 10.1016/j.ab.2011.01.028 ID - Zhang2011 ER - TY - JOUR AU - Moshitch-Moshkovitz, S. AU - Tsarfaty, G. AU - Kaufman, D. W. AU - Stein, G. Y. AU - Shichrur, K. AU - Solomon, E. PY - 2006 DA - 2006// TI - In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met JO - Neoplasia VL - 8 UR - https://doi.org/10.1593/neo.05634 DO - 10.1593/neo.05634 ID - Moshitch-Moshkovitz2006 ER - TY - JOUR AU - Olwill, S. A. AU - Joffroy, C. AU - Gille, H. AU - Vigna, E. AU - Matschiner, G. AU - Allersdorfer, A. PY - 2013 DA - 2013// TI - A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-13-0318 DO - 10.1158/1535-7163.MCT-13-0318 ID - Olwill2013 ER - TY - JOUR AU - Scheltinga AG, T. AU - Lub-de Hooge, M. N. AU - Hinner, M. J. AU - Verheijen, R. B. AU - Allersdorfer, A. AU - Hulsmeyer, M. PY - 2014 DA - 2014// TI - In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.124941 DO - 10.2967/jnumed.113.124941 ID - Scheltinga AG2014 ER - TY - JOUR AU - Mross, K. AU - Richly, H. AU - Fischer, R. AU - Scharr, D. AU - Buchert, M. AU - Stern, A. PY - 2013 DA - 2013// TI - First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0083232 DO - 10.1371/journal.pone.0083232 ID - Mross2013 ER - TY - JOUR AU - Wu, C. AU - Tang, Z. AU - Fan, W. AU - Zhu, W. AU - Wang, C. AU - Somoza, E. PY - 2010 DA - 2010// TI - In vivo positron emission tomography (PET) imaging of mesenchymal-epithelial transition (MET) receptor JO - J Med Chem VL - 53 UR - https://doi.org/10.1021/jm900803q DO - 10.1021/jm900803q ID - Wu2010 ER - TY - JOUR AU - Pool, M. AU - Dam, G. M. AU - de Vries, E. G. PY - 2016 DA - 2016// TI - Emerging opportunities for c-MET visualization in the clinic JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.169771 DO - 10.2967/jnumed.115.169771 ID - Pool2016 ER -